Gene Editing: Opportunities and Implications Across the Food and Ag Value Chain

McKinsey & Company and Morrison & Foerster

28 Sep 2021 12:00 p.m. - 01:00 p.m. EDT

The panel will be moderated and jointly led by leaders from McKinsey & Co. and Morrison & Foerster, who will share their respective perspectives on the opportunities gene editing creates in an evolving technological and regulatory landscape worldwide. The panelists will address key questions relating to:

  • What is possible through gene editing? How does it differ from traditional GMO tech?
  • What is the outlook for gene editing in Europe and China?
  • What is the regulatory landscape in the US?


  • Josh Katz - Partner, McKinsey & Company
  • Michael Ward - Partner, Morrison & Foerster


  • Stacy Amin - Partner, Morrison & Foerster
  • Tom Brennan - Associate Partner, McKinsey & Company
  • Shane Bryan - Associate Partner, McKinsey & Company
  • Wolfgang Schönig - Partner, Morrison & Foerster
  • William (Bill) Tarantino - Partner, Morrison & Foerster



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.